Please assess the completion status of the following clinical trial:

Trial Title: Tolerance of Cereals for Atopic Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infant aged from 4 to 40 months at the time of enrolment~* With atopic symptoms and/or positive Skin Prick Test (SPT) or positive specific RAST-IgE or positive Patch Test~* Infants who received a specific elimination oligoallergenic diet from the study site for at least 5 days before the day of enrolment~* Having obtained his/her signed legal representative's informed consent~Exclusion Criteria:~* Infant on systemic drugs (e.g. antihistamines) according to half-life at time of enrolment~* Congenital illness or malformation that may affect normal growth (especially immunodeficiency)~* Infant whose parents / caregivers cannot be expected to comply with treatment.~* Infant currently participating in another interventional clinical trial

- Gender: ALL
- Minimum Age: 4 Months
- Maximum Age: 4 Years
- Healthy Volunteers: f

Study Arms:
- complete non allergenic cereals (Type: ACTIVE_COMPARATOR): existing commercialized product
- complete non allergenic cereals plus (Type: EXPERIMENTAL): commercialised product with the addition of a novel ingredient

Based on this trial design, predict the completion outcome and termination type (if applicable).